rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2006-12-6
|
pubmed:abstractText |
To discuss exhaustively: 1) the interferon-gamma in inducing and modulating of immune responses; 2) impairment of IFN-gamma production that plays an important role in the persistence of infection, chronicity of inflammation, evolution in fibrosis; 3) in "vivo" effects of combination treatment with recombinant interferon-gamma and alpha in chronic HCV-infection.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0009-9074
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
157
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
457-68
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17147054-Animals,
pubmed-meshheading:17147054-Antiviral Agents,
pubmed-meshheading:17147054-Blood Bactericidal Activity,
pubmed-meshheading:17147054-Clinical Trials as Topic,
pubmed-meshheading:17147054-Drug Therapy, Combination,
pubmed-meshheading:17147054-Hepatitis C, Chronic,
pubmed-meshheading:17147054-Humans,
pubmed-meshheading:17147054-Interferon-alpha,
pubmed-meshheading:17147054-Interferon-gamma,
pubmed-meshheading:17147054-Lymphocytes,
pubmed-meshheading:17147054-Macrophages,
pubmed-meshheading:17147054-Mice,
pubmed-meshheading:17147054-Mice, Transgenic,
pubmed-meshheading:17147054-Neutrophils,
pubmed-meshheading:17147054-Nitric Oxide,
pubmed-meshheading:17147054-Phagocytosis,
pubmed-meshheading:17147054-Recombinant Proteins
|
pubmed:articleTitle |
Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).
|
pubmed:affiliation |
F Magrassi Department of Clinical and Experimental Medicine, II University of Naples School of Medicine, Napoli, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Review,
Retracted Publication
|